Reintroduction of SALSA Aims to Fix Lab PAMA Reporting
Independent laboratories have been pushed to the brink of financial instability in recent years due to the price cuts mandated by the Protecting Access to Medicare Act of 2014 (PAMA). However, as part of a yearslong effort to rectify the problematic pricing and...
3 Things to Know When Billing for Genetic and Molecular Testing
This article was updated with new information on March 5, 2023. As labs throughout the country continue to explore new revenue streams in the face of seemingly endless annual cuts from CMS and commercial payers, many are adding genetic testing and molecular...
Major COVID Testing Changes Expected as Health Emergency Ends
A number of key waivers put in place at the beginning of the COVID-19 Public Health Emergency to facilitate widespread testing will end when the emergency declaration expires on May 11, according to recent updates from CMS. While labs and providers performing COVID...
VALID Act, SALSA Expected to Be Reintroduced
A couple of key laboratory legislative issues that were put on hold at the end of 2022 now appear to be making comebacks as they seek new Congressional champions. Check out the news roundup below for the latest developments on VALID, SALSA, and more. VALID...